FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Critical swing state candidates reveal where they stand on DHS funding after suspected terror attacks

Leftists Tell Conservative Students To Kill Themselves, Use Kirk Assassination Images To Threaten Event

Visit Goes Horribly Wrong: Two California Men Face Felony Charges for Snapping $200K Tusk off Woolly Mammoth Museum Exhibit

Virginia Dems send sweeping gun ban to Spanberger as West Virginia weighs expanding machine-gun access

Vance touts Trump economy gains during North Carolina tour, cites rising home purchases

Former Gettysburg mayor arrested on child sex abuse charges weeks after resignation

Breaking: Jasmine Crockett Security Officer Shot, Killed by SWAT Team

PR exec demands Senate Dems apologize for spreading ‘falsehoods’ about him during heated Noem hearing

Vance reveals $19B fraud uncovered in Minneapolis, hints California is next target

Man accused of attacking TSA officers, seriously injuring Dallas cop at airport

Manhunt for Louisiana man wanted in deadly crash who may have fled state or country continues into sixth month

Trump Kennedy Center’s new leader revealed as Ric Grenell exits top role

Cuban president reveals talks with Trump admin as fuel blockade chokes domestic energy supply and economy

High school senior charged with ‘random’ murder after 68-year-old woman found dead in Massachusetts home

GOP lawmakers would strip citizenship from terrorists after attacks tied to naturalized citizens

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”